AP
PMC

AHL Partners’s PharMerica Corporation PMC Stock Holding History

AHL Partners’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,294
Closed -$498K – 1299
2017
Q1 		$498K Buy
+21,294
New +$525K 0.01% 958
2016
Q4 		– Sell
-12,197
Closed -$342K – 1282
2016
Q3 		$342K Buy
12,197
+3,232
+36% +$82.8K 0.01% 952
2016
Q2 		$221K Buy
+8,965
New +$222K 0.01% 773

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AHL Partners's PMC Position: Q2 2017 in Review

AHL Partners sold out of PharMerica Corporation (PMC) in Q2 2017, closing a stake of 21,294 shares — an estimated $498K sold.

AHL Partners first reported a position in PMC in Q2 2016 and held it in 3 quarters. The position peaked at $498K in Q1 2017. 157 funds tracked by Wall St. Rank hold PMC as of Q2 2017.

  • AHL Partners reported no remaining PharMerica Corporation position as of Q2 2017 after selling out during the quarter.
  • AHL Partners sold 21,294 PharMerica Corporation shares in Q2 2017, an estimated $498K.
  • AHL Partners first reported a position in PharMerica Corporation in Q2 2016 and held it in 3 quarters.
  • AHL Partners's PharMerica Corporation position peaked at $498K in Q1 2017.
  • 157 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2017.

Based on AHL Partners's 13F filing for Q2 2017, filed 14 Aug 2017.